Lung parenchymal abnormalities and outcomes in hospitalized patients with COVID 19 pneumonia: A positive message from a prospective hospital-based longitudinal study for future considerations

Pulmonary fibrosis is one of the commonly reported sequelae with varying frequencies among the survivors of COVID-19. [1 –3] While parenchymal lung abnormalities (PLA) on High Resolution Computed Tomography (HRCT) scan in patients with COVID-19 pneumonia with varying periods of follow up have been reported, pulmonary consequences are clinically significant for the potential of therapeutic intervention and highlighte d as a key research priority [4,5]. We undertook a prospective observational study in RT-PCR confirmed adult (>18 years) COVID-19 patients hospitalized from June –September 2020 at a tertiary care hospital in India to better understand the evolution of the patterns of PLA on HRCT over 12 weeks.
Source: Respiratory Medicine - Category: Respiratory Medicine Authors: Tags: Short communication Source Type: research